Approximately one in every five adults has sleep-disordered breathing (SDB).
An expanding body of scientific evidence has established the potentially adverse effects of untreated sleep apnoea on patients.
Through its strong partnership with the global medical community, ResMed is committed to:
Increasing awareness of SDB, its effects and treatment

Supporting ongoing research on SDB with other health risks

Finding effective clinical solutions to improve the health and lives of SDB patients
Consult our research and clinical papers on sleep apnoea below.

Sleep-disordered breathing and positive airway pressure

Read more research on the topics of sleep-disordered breathing (SDB) and positive airway pressure (PAP).

Diabetes and sleep apnoea

Explore research about diabetes in relation to sleep and respiratory care.

Obesity and sleep apnoea

Read about obesity research in relation to sleep-disordered breathing and respiratory care.

Sleep-related traffic and occupational accidents

Read about research on traffic accidents in relation to sleep and respiratory care.

Screening for OSA

When ignored, Obstructive Sleep Apnoea can become a risk factor. ResMed explains how their innovative screening process can help patients get a proper diagnosis for their OSA.

AutoSet™ technology

Learn more about the differences between fixed pressure and auto-adjusting therapy devices

Mandibular Repositioning Devices

Mandibular Repositioning Devices are often used as an alternative treatment for Obstructive Sleep Apnoea (OSA). Learn about ResMed’s Narval CCTM, a premier and personalised oral therapy device.

Sleep therapy compliance

Read about research on compliance in relation to positive airway pressure therapy.